172 related articles for article (PubMed ID: 20614265)
1. An update on Epstein-Barr virus and nasopharyngeal carcinogenesis.
Perez-Ordoñez B
Head Neck Pathol; 2007 Dec; 1(2):141-5. PubMed ID: 20614265
[No Abstract] [Full Text] [Related]
2. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
3. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.
Zhou L; Jiang W; Ren C; Yin Z; Feng X; Liu W; Tao Q; Yao K
Neoplasia; 2005 Sep; 7(9):809-15. PubMed ID: 16229803
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma in two young brothers and its relationship with Epstein-Barr virus.
Duque CS; Velasquez A; Weiss LM; Arango JC
Am J Otolaryngol; 1998; 19(5):335-8. PubMed ID: 9758184
[No Abstract] [Full Text] [Related]
5. Lymphoepithelioma-like carcinoma and its relationship to Epstein-Barr virus.
Weiss LM; Gaffey MJ; Shibata D
Am J Clin Pathol; 1991 Aug; 96(2):156-8. PubMed ID: 1650531
[No Abstract] [Full Text] [Related]
6. Role of human
Ahmed HG; Suliman RSA; Ashankyty IM; Albieh ZA; Warille AA
J Cancer Res Ther; 2018; 14(3):583-586. PubMed ID: 29893322
[TBL] [Abstract][Full Text] [Related]
7. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
8. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
9. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
10. Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma.
Nakao K; Yuge T; Mochiki M; Nibu K; Sugasawa M
Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):338-40. PubMed ID: 12622545
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis in head and neck: what a surgical pathologist must know.
Hunt JL
Head Neck Pathol; 2008 Jun; 2(2):99-102. PubMed ID: 20614331
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
15. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
16. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.
Lo YM; Leung SF; Chan LY; Lo KW; Zhang J; Chan AT; Lee JC; Hjelm NM; Johnson PJ; Huang DP
Ann N Y Acad Sci; 2000 Apr; 906():99-101. PubMed ID: 10818603
[No Abstract] [Full Text] [Related]
17. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma.
Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K
Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817
[TBL] [Abstract][Full Text] [Related]
18. A new lytic antibody, 7D6, detects Epstein-Barr virus dUTPase in nonkeratinizing undifferentiated nasopharyngeal carcinomas.
Nicholls JM; Sommer P; Kremmer E; Ong KS; Fung K; Lee JM; Ng MH; Grässer FA
Lab Invest; 1998 Aug; 78(8):1031-2. PubMed ID: 9714190
[No Abstract] [Full Text] [Related]
19. Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
Kottaridis SD; Panotopoulou E; Diamantis I; Goula I; Danilidis J; Fountzilas G
Anticancer Res; 1996; 16(2):785-9. PubMed ID: 8687129
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
